A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
NCT 05277168 Brief Summary The study (dose escalation/expansion) is being conducted to…
Read more arrow_forwardNCT 05277168 Brief Summary The study (dose escalation/expansion) is being conducted to…
Read more arrow_forwardNCT 05800015 Brief Summary This study is researching an investigational drug called…
Read more arrow_forwardNCT 02582697 Brief Summary The purpose of this study is to determine…
Read more arrow_forwardNCT 03067181 Brief Summary This phase III trial studies how well active…
Read more arrow_forwardNCT 06597721 Brief Summary Adcendo ApS is conducting a phase 1 study…
Read more arrow_forwardNCT 07063875 Brief Summary A recent clinical trial found that after 36…
Read more arrow_forwardACTRN 12622000016730 Brief Summary Patients with previously untreated HER2-positive locally advanced or…
Read more arrow_forwardNCT 06333951 Brief Summary The study aims to determine maximum tolerated dose…
Read more arrow_forwardACTRN 12621000439842 Brief Summary The aim is to demonstrate that targeting rising…
Read more arrow_forwardNCT 05725291 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forward